18 F-Fluoride Positron Emission Tomographic Imaging of Penile Arteries and Erectile Dysfunction

Takehiro Nakahara, Jagat Narula, Jan G.P. Tijssen, Sunil Agarwal, Mohammed M. Chowdhury, Patrick A. Coughlin, Marc R. Dweck, James H.F. Rudd, Masahiro Jinzaki, John Mulhall, H. William Strauss

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Fluorine-18 sodium fluoride (NaF), a bone-seeking radiopharmaceutical used to detect osseous metastases, localizes in regions of microcalcification in atherosclerosis. Objectives: To determine if atherosclerosis of penile arteries plays a role in erectile dysfunction (ED), this study analyzed NaF images in prostate cancer patients. Methods: NaF positron emission tomography–computed tomography bone scans were evaluated in 437 prostate cancer patients (age 66.6 ± 8.7 years). Their urologic histories were reviewed for prevalent ED (diagnosed before the scan date) or incident ED (no ED at first scan, but developed during 1-year follow-up); patients with no ED (neither before the scan nor during follow-up) were included as a control group. A semicircular region of interest was set on the dorsal one-half of the penis (to avoid residual excreted activity in the urethra) on 5 contiguous slices at the base of the penis on positron emission tomography–computed tomography coronal reconstructions, and the average standardized uptake value (SUVmax) was described as NaF uptake. Results: Of 437 patients, 336 (76.9%) had prevalent ED, 60 incident ED (13.7%), and 41 had no ED (9.4%). SUVmax in patients with prevalent (median 1.88; interquartile range [IQR]: 1.67 to 2.16) or incident (median 1.86; IQR: 1.72 to 2.08) ED was significantly higher than no ED (median 1.42; IQR: 1.25 to 1.54) patients (p < 0.001). After adjustment for other risk factors, the odds ratio of prevalent or incident ED was 25.2 (95% confidence interval: 9.5 to 67.0) for every 0.5-U increment in SUVmax with receptor operating characteristic area of 0.91 (95% confidence interval: 0.88 to 0.94). Conclusions: NaF uptake in penile vessels suggests that atherosclerosis is associated with ED in prostate cancer patients. The importance of NaF uptake needs to be tested in noncancer subjects and cause-effect relationship needs to be established.

Original languageEnglish
Pages (from-to)1386-1394
Number of pages9
JournalJournal of the American College of Cardiology
Volume73
Issue number12
DOIs
Publication statusPublished - 2019 Apr 2

Fingerprint

Erectile Dysfunction
Fluorides
Arteries
Electrons
Prostatic Neoplasms
Atherosclerosis
Penis
Positron-Emission Tomography
Confidence Intervals
Calcinosis
Bone and Bones
Sodium Fluoride
Radiopharmaceuticals
Fluorine
Urethra
Odds Ratio
Neoplasm Metastasis

Keywords

  • atherosclerosis
  • calcification
  • erectile dysfunction
  • NaF
  • sodium fluoride

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Nakahara, T., Narula, J., Tijssen, J. G. P., Agarwal, S., Chowdhury, M. M., Coughlin, P. A., ... Strauss, H. W. (2019). 18 F-Fluoride Positron Emission Tomographic Imaging of Penile Arteries and Erectile Dysfunction Journal of the American College of Cardiology, 73(12), 1386-1394. https://doi.org/10.1016/j.jacc.2018.10.076

18 F-Fluoride Positron Emission Tomographic Imaging of Penile Arteries and Erectile Dysfunction . / Nakahara, Takehiro; Narula, Jagat; Tijssen, Jan G.P.; Agarwal, Sunil; Chowdhury, Mohammed M.; Coughlin, Patrick A.; Dweck, Marc R.; Rudd, James H.F.; Jinzaki, Masahiro; Mulhall, John; Strauss, H. William.

In: Journal of the American College of Cardiology, Vol. 73, No. 12, 02.04.2019, p. 1386-1394.

Research output: Contribution to journalArticle

Nakahara, T, Narula, J, Tijssen, JGP, Agarwal, S, Chowdhury, MM, Coughlin, PA, Dweck, MR, Rudd, JHF, Jinzaki, M, Mulhall, J & Strauss, HW 2019, '18 F-Fluoride Positron Emission Tomographic Imaging of Penile Arteries and Erectile Dysfunction ', Journal of the American College of Cardiology, vol. 73, no. 12, pp. 1386-1394. https://doi.org/10.1016/j.jacc.2018.10.076
Nakahara, Takehiro ; Narula, Jagat ; Tijssen, Jan G.P. ; Agarwal, Sunil ; Chowdhury, Mohammed M. ; Coughlin, Patrick A. ; Dweck, Marc R. ; Rudd, James H.F. ; Jinzaki, Masahiro ; Mulhall, John ; Strauss, H. William. / 18 F-Fluoride Positron Emission Tomographic Imaging of Penile Arteries and Erectile Dysfunction In: Journal of the American College of Cardiology. 2019 ; Vol. 73, No. 12. pp. 1386-1394.
@article{a384307a77af4a4bbac0c2815a848466,
title = "18 F-Fluoride Positron Emission Tomographic Imaging of Penile Arteries and Erectile Dysfunction",
abstract = "Background: Fluorine-18 sodium fluoride (NaF), a bone-seeking radiopharmaceutical used to detect osseous metastases, localizes in regions of microcalcification in atherosclerosis. Objectives: To determine if atherosclerosis of penile arteries plays a role in erectile dysfunction (ED), this study analyzed NaF images in prostate cancer patients. Methods: NaF positron emission tomography–computed tomography bone scans were evaluated in 437 prostate cancer patients (age 66.6 ± 8.7 years). Their urologic histories were reviewed for prevalent ED (diagnosed before the scan date) or incident ED (no ED at first scan, but developed during 1-year follow-up); patients with no ED (neither before the scan nor during follow-up) were included as a control group. A semicircular region of interest was set on the dorsal one-half of the penis (to avoid residual excreted activity in the urethra) on 5 contiguous slices at the base of the penis on positron emission tomography–computed tomography coronal reconstructions, and the average standardized uptake value (SUVmax) was described as NaF uptake. Results: Of 437 patients, 336 (76.9{\%}) had prevalent ED, 60 incident ED (13.7{\%}), and 41 had no ED (9.4{\%}). SUVmax in patients with prevalent (median 1.88; interquartile range [IQR]: 1.67 to 2.16) or incident (median 1.86; IQR: 1.72 to 2.08) ED was significantly higher than no ED (median 1.42; IQR: 1.25 to 1.54) patients (p < 0.001). After adjustment for other risk factors, the odds ratio of prevalent or incident ED was 25.2 (95{\%} confidence interval: 9.5 to 67.0) for every 0.5-U increment in SUVmax with receptor operating characteristic area of 0.91 (95{\%} confidence interval: 0.88 to 0.94). Conclusions: NaF uptake in penile vessels suggests that atherosclerosis is associated with ED in prostate cancer patients. The importance of NaF uptake needs to be tested in noncancer subjects and cause-effect relationship needs to be established.",
keywords = "atherosclerosis, calcification, erectile dysfunction, NaF, sodium fluoride",
author = "Takehiro Nakahara and Jagat Narula and Tijssen, {Jan G.P.} and Sunil Agarwal and Chowdhury, {Mohammed M.} and Coughlin, {Patrick A.} and Dweck, {Marc R.} and Rudd, {James H.F.} and Masahiro Jinzaki and John Mulhall and Strauss, {H. William}",
year = "2019",
month = "4",
day = "2",
doi = "10.1016/j.jacc.2018.10.076",
language = "English",
volume = "73",
pages = "1386--1394",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "12",

}

TY - JOUR

T1 - 18 F-Fluoride Positron Emission Tomographic Imaging of Penile Arteries and Erectile Dysfunction

AU - Nakahara, Takehiro

AU - Narula, Jagat

AU - Tijssen, Jan G.P.

AU - Agarwal, Sunil

AU - Chowdhury, Mohammed M.

AU - Coughlin, Patrick A.

AU - Dweck, Marc R.

AU - Rudd, James H.F.

AU - Jinzaki, Masahiro

AU - Mulhall, John

AU - Strauss, H. William

PY - 2019/4/2

Y1 - 2019/4/2

N2 - Background: Fluorine-18 sodium fluoride (NaF), a bone-seeking radiopharmaceutical used to detect osseous metastases, localizes in regions of microcalcification in atherosclerosis. Objectives: To determine if atherosclerosis of penile arteries plays a role in erectile dysfunction (ED), this study analyzed NaF images in prostate cancer patients. Methods: NaF positron emission tomography–computed tomography bone scans were evaluated in 437 prostate cancer patients (age 66.6 ± 8.7 years). Their urologic histories were reviewed for prevalent ED (diagnosed before the scan date) or incident ED (no ED at first scan, but developed during 1-year follow-up); patients with no ED (neither before the scan nor during follow-up) were included as a control group. A semicircular region of interest was set on the dorsal one-half of the penis (to avoid residual excreted activity in the urethra) on 5 contiguous slices at the base of the penis on positron emission tomography–computed tomography coronal reconstructions, and the average standardized uptake value (SUVmax) was described as NaF uptake. Results: Of 437 patients, 336 (76.9%) had prevalent ED, 60 incident ED (13.7%), and 41 had no ED (9.4%). SUVmax in patients with prevalent (median 1.88; interquartile range [IQR]: 1.67 to 2.16) or incident (median 1.86; IQR: 1.72 to 2.08) ED was significantly higher than no ED (median 1.42; IQR: 1.25 to 1.54) patients (p < 0.001). After adjustment for other risk factors, the odds ratio of prevalent or incident ED was 25.2 (95% confidence interval: 9.5 to 67.0) for every 0.5-U increment in SUVmax with receptor operating characteristic area of 0.91 (95% confidence interval: 0.88 to 0.94). Conclusions: NaF uptake in penile vessels suggests that atherosclerosis is associated with ED in prostate cancer patients. The importance of NaF uptake needs to be tested in noncancer subjects and cause-effect relationship needs to be established.

AB - Background: Fluorine-18 sodium fluoride (NaF), a bone-seeking radiopharmaceutical used to detect osseous metastases, localizes in regions of microcalcification in atherosclerosis. Objectives: To determine if atherosclerosis of penile arteries plays a role in erectile dysfunction (ED), this study analyzed NaF images in prostate cancer patients. Methods: NaF positron emission tomography–computed tomography bone scans were evaluated in 437 prostate cancer patients (age 66.6 ± 8.7 years). Their urologic histories were reviewed for prevalent ED (diagnosed before the scan date) or incident ED (no ED at first scan, but developed during 1-year follow-up); patients with no ED (neither before the scan nor during follow-up) were included as a control group. A semicircular region of interest was set on the dorsal one-half of the penis (to avoid residual excreted activity in the urethra) on 5 contiguous slices at the base of the penis on positron emission tomography–computed tomography coronal reconstructions, and the average standardized uptake value (SUVmax) was described as NaF uptake. Results: Of 437 patients, 336 (76.9%) had prevalent ED, 60 incident ED (13.7%), and 41 had no ED (9.4%). SUVmax in patients with prevalent (median 1.88; interquartile range [IQR]: 1.67 to 2.16) or incident (median 1.86; IQR: 1.72 to 2.08) ED was significantly higher than no ED (median 1.42; IQR: 1.25 to 1.54) patients (p < 0.001). After adjustment for other risk factors, the odds ratio of prevalent or incident ED was 25.2 (95% confidence interval: 9.5 to 67.0) for every 0.5-U increment in SUVmax with receptor operating characteristic area of 0.91 (95% confidence interval: 0.88 to 0.94). Conclusions: NaF uptake in penile vessels suggests that atherosclerosis is associated with ED in prostate cancer patients. The importance of NaF uptake needs to be tested in noncancer subjects and cause-effect relationship needs to be established.

KW - atherosclerosis

KW - calcification

KW - erectile dysfunction

KW - NaF

KW - sodium fluoride

UR - http://www.scopus.com/inward/record.url?scp=85063097302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063097302&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2018.10.076

DO - 10.1016/j.jacc.2018.10.076

M3 - Article

C2 - 30846336

AN - SCOPUS:85063097302

VL - 73

SP - 1386

EP - 1394

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 12

ER -